InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Wainer Andrea F, Vice-Présidente Exécutive. Director active across 3 companies, notably Abbott Laboratories. Cumulatively, 28 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €1.5m. Activity tracked since 3 June 2021. The latest transaction was disclosed on 11 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Wainer Andrea F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报28 总计
747 股0Comm Stock - $.16-2/3 valueSEC:0001778070-26-000002:0
19,769 股@ US$6.0777.3% 占其流量Common StockSEC:0000711377-25-000055:0
6,090 股@ US$5.69100.0% 占其流量Common StockSEC:0000711377-25-000022:0
1,160 股0Comm Stock - $.16-2/3 valueSEC:0000006281-25-000058:0
7,313 股@ US$135.878.6% 占其流量Common shares without par valueSEC:0001415889-25-006798:0
949 股@ US$138.171.1% 占其流量Common shares without par valueSEC:0001415889-25-006798:1
12,278 股0Common shares without par valueSEC:0001415889-25-005920:0
8,339 股@ US$120.058.3% 占其流量Common shares without par valueSEC:0001415889-24-006422:0
12,500 股@ US$59.946.2% 占其流量Common shares without par valueSEC:0001415889-24-005576:0
12,500 股@ US$120.0012.5% 占其流量Common shares without par valueSEC:0001415889-24-005576:1
13,677 股0Common shares without par valueSEC:0001415889-24-005110:0
25,000 股@ US$44.409.2% 占其流量Common shares without par valueSEC:0001415889-24-002080:0
15,000 股@ US$44.405.5% 占其流量Common shares without par valueSEC:0001415889-23-016642:0
5,000 股@ US$38.401.6% 占其流量Common shares without par valueSEC:0001415889-23-012074:0
8,226 股@ US$47.003.2% 占其流量Common shares without par valueSEC:0001415889-23-007254:0
7,531 股@ US$99.776.4% 占其流量Common shares without par valueSEC:0001415889-23-003921:0
18,233 股0Common shares without par valueSEC:0001415889-23-003068:0
1,768 股@ US$117.510.0001% mcap4.7% 占其流量Common shares without par valueSEC:0001415889-22-006224:0
6,126 股@ US$122.417.1% 占其流量Common shares without par valueSEC:0001415889-22-002201:0
18,972 股0Common shares without par valueSEC:0001415889-22-001747:0
3,000 股@ US$47.001.3% 占其流量Common shares without par valueSEC:0001415889-21-006265:0
7,500 股@ US$47.003.3% 占其流量Common shares without par valueSEC:0001415889-21-006161:0
7,000 股@ US$47.003.1% 占其流量Common shares without par valueSEC:0001415889-21-005968:0
4,500 股@ US$47.002.0% 占其流量Common shares without par valueSEC:0001415889-21-005788:0
5,000 股@ US$47.002.2% 占其流量Common shares without par valueSEC:0001415889-21-005271:0
28 条申报中的 25 条
About Wainer Andrea F
Wainer Andrea F is Vice-Présidente Exécutive and has 28 filings in total. Among the sampled recent filings, they cover the period from 2021-06-07 to 2026-03-12, with sum_sell_eur of 1511507 and sum_buy_eur of 0. The companies mentioned are Abbott Laboratories, Analog Devices INC and NEOGEN CORP, and the modal transaction nature is Levée d'options.
